Anzupgo 20 mg/g, Creme

7680693300026 CH-69330 Creme

Associated product:

ANZUPGO crème 20 mg/g tb 60 g
Anzupgo 20 mg/g, Creme
Anzupgo 20 mg/g, Creme
Anzupgo 20 mg/g, Creme
1 / 3
google

Article details

Package size
60
Selling units
60
Measure
g
Galenic form
Creme
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/02/2025
Patient information leaflet
Français
04/02/2025
Patient information leaflet
Italien
04/02/2025
Summary of Product Characteristics
Allemand
04/02/2025
Summary of Product Characteristics
Français
04/02/2025
Summary of Product Characteristics
Italien
04/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
72.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.2 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 637.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2025

Authorization holder

Leo Pharmaceutical Products Sarath Ltd.

8302 Kloten

Authorization information

Swissmedic authorization number
69330
Drug name
Anzupgo, Creme
Galenic form
CREM
ATC Code
D11AH11
Authorization status
Z
Dispensing category
B
First authorization
13/11/2024
Authorization expiration date
12/11/2029
IT Number
10.04.0.
Domain
Human medicine
Field of application
Chronisches Handekzem

Package details

Description (FR)
ANZUPGO crème 20 mg/g tb 60 g
Description (DE)
ANZUPGO Creme 20 mg/g Tb 60 g
Market launch
13/11/2024
Narcotic (BTM)
No